StemTek Therapeutics Overview

  • Founded
  • 2013

Founded
  • Status
  • Out of Business

  • Latest Deal Type
  • Liquidation

StemTek Therapeutics General Information

Description

Developer novel drugs designed for cancer targeting cancer stem cells. The company is accelerating drug discovery in cancer using cutting-edge technology, world-class science, and a stem cell-centric point of view for cancer therapy, enabling physicians to treat cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • BIC BIZKAIA, Parque Tecnológico de Bizkaia
  • C/Astondo Bidea, s/n
  • 48160 Derio
  • Spain

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StemTek Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 21-Aug-2020 Completed Bankruptcy: Liquidation
3. Accelerator/Incubator 12-Apr-2017 Completed Generating Revenue
2. Grant 12-Dec-2016 $50K Completed Generating Revenue
1. Early Stage VC 01-Jan-2016 Completed Startup
To view StemTek Therapeutics’s complete valuation and funding history, request access »

StemTek Therapeutics Patents

StemTek Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3464570-A1 Methods for producing cancer stem cell spheroids Withdrawn 02-Jun-2016 0000000000
US-20200283733-A1 Methods for producing cancer stem cell spheroids Pending 02-Jun-2016 0000000000
JP-2019517278-A Method of generating cancer stem cell spheroids Pending 02-Jun-2016 0000000000
CA-3026012-A1 Methods for producing cancer stem cell spheroids Pending 02-Jun-2016 0000000000
GB-201609663-D0 Methods for producing cancer stem cell spheroids Ceased 02-Jun-2016 C12N5/0695
To view StemTek Therapeutics’s complete patent history, request access »